NON-MUSCLE INVASIVE BLADDER CANCER
Clinical trials for NON-MUSCLE INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for bladder cancer patients: virus therapy targets tumors when standard treatment fails
Disease control OngoingThis study tests a new treatment called cretostimogene grenadenorepvec for people with a type of bladder cancer (non-muscle invasive) that did not get better after standard therapy (BCG). The treatment uses a modified virus to attack cancer cells. About 190 adults will take part …
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated May 26, 2026 05:39 UTC
-
New drug targets Hard-to-Treat bladder cancers
Disease control OngoingThis study tests a new drug called TYRA300 in people with advanced bladder cancer or other solid tumors that have a specific gene change (FGFR3). The goal is to find a safe dose and see if the drug can shrink tumors. About 310 adults whose cancer has not responded to standard tre…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 26, 2026 05:27 UTC
-
Bladder cancer trial combines two treatments to fight High-Risk disease
Disease control OngoingThis study tests a combination of two drugs—BCG (a standard immunotherapy) and durvalumab (a newer immunotherapy)—in 100 adults with high-risk non-muscle-invasive bladder cancer who have not received BCG before. The goal is to see if the combination is safe and effective at contr…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Virus therapy aims to keep bladder cancer from coming back
Disease control OngoingThis early-phase trial tests a new treatment called CG0070, a virus designed to attack cancer cells, in 20 people with intermediate-risk non-muscle invasive bladder cancer. After having visible tumors removed during a scope procedure, patients receive CG0070 directly into the bla…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New drug combo could rival standard bladder cancer therapy
Disease control OngoingThis study tests whether a combination of two chemotherapy drugs (Gemcitabine and Docetaxel) works as well as the standard BCG treatment for high-grade non-muscle invasive bladder cancer. About 870 patients who have not received BCG before will be randomly assigned to one of the …
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Bladder cancer trial: could adding immunotherapy to standard care keep cancer away longer?
Disease control OngoingThis phase 3 study tests whether adding the immunotherapy drug durvalumab to standard BCG treatment helps keep high-risk bladder cancer from coming back. About 1,000 adults with non-muscle-invasive bladder cancer who have not had BCG before will be randomly assigned to get either…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Simple urine test may spare low-risk bladder cancer patients from unnecessary treatments
Diagnosis OngoingThis study looks at whether a urine test for a genetic marker called SIX6 can predict if low-risk bladder cancer will come back after surgery. Researchers will compare SIX6 levels in 177 patients who had their tumor removed. The goal is to help doctors decide who truly needs foll…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER
Phase: NA • Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated May 26, 2026 05:30 UTC